Imunon, Inc.
USD1.67
-0.10 (-5.65%)
CEO
Stacy R. Lindborg
IPO Date
1999-03-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.09
Prev. Close
$1.77
Day Low
$1.64
Day High
$2.12
52W Low
$1.59
52W High
$8.19
Market Cap
$0.00B
Volume
3.53M
| 0 |
| $0.00 |
| 7 Jul 2026 | Eylward Susan | General Counsel and Corp Sec | A-Award | Acquired | 920 | $1.91 |
| 7 Jul 2026 | Eylward Susan | General Counsel and Corp Sec | S-Sale | Disposed | 920 | $1.88 |
| 7 Jul 2026 | Faller Douglas Vincent | Chief Medical Officer | A-Award | Acquired | 1,308 | $1.91 |
| 7 Jul 2026 | Lindborg Stacy | director, officer: President and CEO | A-Award | Acquired | 2,534 | $1.91 |
| 29 Jun 2026 | Faller Douglas Vincent | Chief Medical Officer | A-Award | Acquired | 21,896 | $1.72 |
| 29 Jun 2026 | Eylward Susan | General Counsel and Corp Sec | A-Award | Acquired | 14,696 | $1.72 |
| 29 Jun 2026 | Eylward Susan | General Counsel and Corp Sec | S-Sale | Disposed | 11,800 | $1.75 |
| 29 Jun 2026 | Tardugno Michael H | director, officer: Executive Chairman of Board | A-Award | Acquired | 42,519 | $1.72 |